Planned 15,234-share SailPoint (NYSE: SAIL) insider stock sale filed
Rhea-AI Filing Summary
SailPoint insider Brian Carolan filed a notice under Rule 144 to sell 15,234 shares of common stock through Morgan Stanley Smith Barney on Nasdaq around January 6, 2026, with an aggregate market value of $292,963.42. The filing notes that 561,625,760 shares of common stock were outstanding.
The shares to be sold come from a larger block of 111,257 shares of common stock acquired on January 5, 2026 via RSU vesting, described as compensation from the issuer. The notice also lists recent activity over the prior three months, including sales of 36,165, 36,899 and 84,699 shares of common stock by Carolan, with gross proceeds of $815,654.56, $828,289.38 and $1,899,229.42, respectively.
Positive
- None.
Negative
- None.
FAQ
What does SailPoint (SAIL) disclose in this Rule 144 filing?
The filing discloses that insider Brian Carolan plans to sell 15,234 shares of SailPoint common stock through Morgan Stanley Smith Barney on Nasdaq, with an aggregate market value of $292,963.42.
When were the SailPoint shares being sold under Rule 144 acquired?
The common stock being sold was acquired on January 5, 2026 through RSU vesting, with 111,257 shares acquired from the issuer as compensation.
How many SailPoint shares are outstanding according to this notice?
The notice states that there were 561,625,760 shares of SailPoint common stock outstanding.
What prior SailPoint stock sales by Brian Carolan are listed in the last 3 months?
The filing lists three common stock sales by Brian Carolan: 36,165 shares on October 7, 2025 for $815,654.56, 36,899 shares on October 8, 2025 for $828,289.38, and 84,699 shares on October 9, 2025 for $1,899,229.42.
Which broker and exchange are involved in the planned SailPoint share sale?
The planned sale of 15,234 SailPoint common shares is through Morgan Stanley Smith Barney LLC, with trading on the Nasdaq exchange.
What representation does the insider make in this SailPoint Rule 144 notice?
The insider represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions can constitute federal criminal violations.